AbbVie Raised Its FY24 Adjusted EPS Guidance Floor From $10.70 To $11.00 Compared To Consensus Of $11.07
Portfolio Pulse from Benzinga Newsdesk
AbbVie has increased its FY24 adjusted EPS guidance floor from $10.70 to $11.00, which is slightly below the consensus of $11.07.
October 27, 2023 | 11:48 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AbbVie's raised FY24 adjusted EPS guidance floor is slightly below the consensus, which may lead to mixed market reactions.
AbbVie's raised EPS guidance for FY24 is slightly below the market consensus. This could lead to mixed reactions from investors, as the increase in guidance is a positive sign, but it being below consensus could be seen as a negative. Therefore, the short-term impact on the stock price is uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100